0001437749-20-024126.txt : 20201118
0001437749-20-024126.hdr.sgml : 20201118
20201118083333
ACCESSION NUMBER: 0001437749-20-024126
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201116
FILED AS OF DATE: 20201118
DATE AS OF CHANGE: 20201118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ELDER WILLIAM ROBERT
CENTRAL INDEX KEY: 0001828068
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37942
FILM NUMBER: 201323121
MAIL ADDRESS:
STREET 1: 1317 CARLTON AVENUE
STREET 2: SUITE 200
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Diffusion Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001053691
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300645032
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: (434) 220-0718
MAIL ADDRESS:
STREET 1: 2020 AVON COURT
STREET 2: SUITE 4
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
FORMER COMPANY:
FORMER CONFORMED NAME: RestorGenex Corp
DATE OF NAME CHANGE: 20140307
FORMER COMPANY:
FORMER CONFORMED NAME: Stratus Media Group, Inc
DATE OF NAME CHANGE: 20080722
FORMER COMPANY:
FORMER CONFORMED NAME: FERIS INTERNATIONAL, INC.
DATE OF NAME CHANGE: 20080228
4
1
rdgdoc.xml
FORM 4
X0306
4
2020-11-16
0001053691
Diffusion Pharmaceuticals Inc.
DFFN
0001828068
ELDER WILLIAM ROBERT
1317 CARLTON AVENUE, SUITE 200
CHARLOTTESVILLE
VA
22902
1
GC & Secretary
Common Stock
2020-11-16
4
P
0
10000
0.67
A
10000
D
Common Stock
2020-11-17
4
P
0
5000
0.63
A
15000
D
The price reported is a weighted average price. The shares were purchased in multiple open-market transactions at prices ranging from $0.6492 to $0.6890, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares sold at each separate price within such range.
The price reported is a weighted average price. The shares were purchased in multiple open-market transactions at prices ranging from $0.6234 to $0.6298, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares sold at each separate price within such range.
/s/ William R. Elder
2020-11-18